199 related articles for article (PubMed ID: 2344174)
21. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
[TBL] [Abstract][Full Text] [Related]
22. Newer beta-lactam agents and the Bacteroides fragilis group.
Cuchural GJ
Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
[TBL] [Abstract][Full Text] [Related]
23. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of the Bacteroides fragilis group in the United States in 1981.
Tally FP; Cuchural GJ; Jacobus NV; Gorbach SL; Aldridge KE; Cleary TJ; Finegold SM; Hill GB; Iannini PB; McCloskey RV; O'Keefe JP; Pierson CL
Antimicrob Agents Chemother; 1983 Apr; 23(4):536-40. PubMed ID: 6859833
[TBL] [Abstract][Full Text] [Related]
26. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
[TBL] [Abstract][Full Text] [Related]
27. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
Borobio MV; Domínguez MC; Pallares JA; Perea EJ
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
[TBL] [Abstract][Full Text] [Related]
29. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Aldridge KE
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
De Almeida AE; De Uzeda M
Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
Stratton CW; Weeks LS; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
[TBL] [Abstract][Full Text] [Related]
33. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
34. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
Aldridge KE; Henderberg A; Sanders CV
J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
[TBL] [Abstract][Full Text] [Related]
35. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
36. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.
Snydman DR; McDermott L; Cuchural GJ; Hecht DW; Iannini PB; Harrell LJ; Jenkins SG; O'Keefe JP; Pierson CL; Rihs JD; Yu VL; Finegold SM; Gorbach SL
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S54-65. PubMed ID: 8953108
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
[TBL] [Abstract][Full Text] [Related]
38. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
Wasilauskas BL
Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.
Appleman MD; Heseltine PN; Cherubin CE
Rev Infect Dis; 1991; 13(1):12-8. PubMed ID: 2017610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
